{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T05:54:06Z","timestamp":1780898046621,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,27]],"date-time":"2013-10-27T00:00:00Z","timestamp":1382832000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00408-013-9518-9","type":"journal-article","created":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T10:40:04Z","timestamp":1382784004000},"page":"151-158","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of Once and Twice Daily Radiotherapy for Limited Stage Small-Cell Lung Cancer"],"prefix":"10.1007","volume":"192","author":[{"given":"Abhilash","family":"Gazula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,27]]},"reference":[{"key":"9518_CR1","volume-title":"Cancer facts and figures\u00a02012","author":"American Cancer Society","year":"2012","unstructured":"American Cancer Society (2012) Cancer facts and figures\u00a02012. American Cancer Society, Atlanta"},{"key":"9518_CR2","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1200\/JCO.2005.04.4859","volume":"24","author":"R Govindan","year":"2006","unstructured":"Govindan R, Page N, Morgensztern D et al (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30\u00a0years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24:4539\u20134544","journal-title":"J Clin Oncol"},{"key":"9518_CR3","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199212033272302","volume":"327","author":"JP Pignon","year":"1992","unstructured":"Pignon JP, Arriagada R, Ihde DC et al (1992) A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327:1618\u20131624","journal-title":"N Engl J Med"},{"key":"9518_CR4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.1992.10.6.890","volume":"10","author":"P Warde","year":"1992","unstructured":"Warde P, Payne D (1992) Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890\u2013895","journal-title":"J Clin Oncol"},{"key":"9518_CR5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","volume":"340","author":"AT Turrisi 3rd","year":"1999","unstructured":"Turrisi AT 3rd, Kim K, Blum R et al (1999) Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265\u2013271","journal-title":"N Engl J Med"},{"key":"9518_CR6","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1200\/JCO.1998.16.11.3528","volume":"16","author":"NC Choi","year":"1998","unstructured":"Choi NC, Herndon JE II, Rosenman J et al (1998) Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol 16:3528\u20133536","journal-title":"J Clin Oncol"},{"issue":"2","key":"9518_CR7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ijrobp.2003.10.021","volume":"59","author":"JA Bogart","year":"2004","unstructured":"Bogart JA, Herndon JE II, Lyss AP et al (2004) 70\u00a0Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808. Int J Radiat Oncol Biol Phys 59(2):460\u2013468","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"9518_CR8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(02)03232-7","volume":"54","author":"B Movsas","year":"2002","unstructured":"Movsas B, Moughan J, Komaki R (2002) Radiotherapy (RT) patterns of care study (PCS) in lung carcinoma [Abstract]. Int J Radiat Oncol Biol Phys 54(Suppl 1):101","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9518_CR9","unstructured":"NCI Clinical Trials (PDQ) Phase III randomized study of three different thoracic radiotherapy regimens in patients with limited-stage small cell lung cancer receiving cisplatin and etoposide [Internet]. http:\/\/www.cancer.gov\/clinicaltrials\/search\/view?cdrid=588879&version=healthprofessional Accessed 22 August 2012"},{"key":"9518_CR10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"9518_CR11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1378\/chest.08-0978","volume":"136","author":"FC Detterbeck","year":"2009","unstructured":"Detterbeck FC, Boffa DJ, Tanoue LT (2009) The new lung cancer staging system. Chest 136(1):260\u2013271","journal-title":"Chest"},{"key":"9518_CR12","unstructured":"NCI Common Terminology Criteria for Adverse Events (CTCAE) v.4 data files [Internet]. http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/About.html Accessed 17 May 2010"},{"issue":"2","key":"9518_CR13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u2013247","journal-title":"Eur J Cancer"},{"issue":"1","key":"9518_CR14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2010.09.004","volume":"82","author":"M Machtay","year":"2012","unstructured":"Machtay M, Bae K, Movsas B et al (2012) Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 82(1):425\u2013434","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"22","key":"9518_CR15","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1200\/JCO.2012.41.6677","volume":"30","author":"A Mauguen","year":"2012","unstructured":"Mauguen A, Le Pechoux C, Saunders MI et al (2012) Hyperfractionated or accelerated radiotherapy in lung cancer; an individual patient data meta-analysis. J Clin Oncol 30(22):2788\u20132797","journal-title":"J Clin Oncol"},{"issue":"4","key":"9518_CR16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ijrobp.2005.09.025","volume":"64","author":"K Tsujino","year":"2006","unstructured":"Tsujino K, Hirota S, Kotani Y et al (2006) Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: dose-volume histogram analysis and comparison with conventional chemoradiation. Int J Radiat Oncol Biol Phys 64(4):1100\u20131105","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"9518_CR17","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijrobp.2009.03.069","volume":"76","author":"N Tomita","year":"2010","unstructured":"Tomita N, Kodaira T, Hida T et al (2010) The impact of radiation dose and fractionation on outcomes for limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 76(4):1121\u20131126","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"9518_CR18","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1200\/JCO.1995.13.10.2606","volume":"13","author":"M Roach 3rd","year":"1995","unstructured":"Roach M 3rd, Gandara DR, Yuo HS et al (1995) Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol 13(10):2606\u20132612","journal-title":"J Clin Oncol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-013-9518-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-013-9518-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-013-9518-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:37:56Z","timestamp":1559068676000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-013-9518-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,27]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["9518"],"URL":"https:\/\/doi.org\/10.1007\/s00408-013-9518-9","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,27]]}}}